Dr. Thomas Fruh – CEO – Bachem
Click HERE to download the PDF version
Bachem is an independent, technology-based, public company, specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative biochemicals for research purposes. Bachem’s founding vision is to be the undisputed leader in peptides. In continuing to fulfil this vision, the company has taken the decision to re-focus on its core business and to grow in peptides. In order to understand this change of strategy, Chimica Oggi – Chemistry Today interviewed the CEO of the company, Dr. Thomas Früh.
Diversification has been one means to achieve future growth and this has been represented in your slogan “Leading beyond peptides”. Why has Bachem decided to re-focus on peptides?
After a thorough strategic planning process wher ...